SrasV1, Ncbi, Merge, bibRecord, 001A37

Heparan sulfate is a binding molecule but not a receptor for CEACAM1-independent infection of murine coronavirus.

Identifieur interne : 001A37 ( Ncbi/Merge ); précédent : 001A36; suivant : 001A38

Heparan sulfate is a binding molecule but not a receptor for CEACAM1-independent infection of murine coronavirus.

Auteurs : Rie Watanabe [Japon] ; Stanley G. Sawicki ; Fumihiro Taguchi

Source :

Virology [ 0042-6822 ] ; 2007.

RBID : pubmed:17692355

Descripteurs français

KwdFr :
- Animaux, Antigène carcinoembryonnaire (physiologie), Coronavirus (), Coronavirus (pathogénicité), Coronavirus (physiologie), Cricetinae, Héparitine sulfate (métabolisme), Infections à coronavirus (physiopathologie), Liaison aux protéines, Lignée cellulaire, Membrane cellulaire (virologie), Rein, Récepteurs viraux (physiologie), Sites de fixation, Souris, Séquence d'acides aminés, Virulence.
MESH :
- métabolisme : Héparitine sulfate.
- pathogénicité : Coronavirus.
- physiologie : Antigène carcinoembryonnaire, Coronavirus, Récepteurs viraux.
- physiopathologie : Infections à coronavirus.
- virologie : Membrane cellulaire.
- Animaux, Coronavirus, Cricetinae, Liaison aux protéines, Lignée cellulaire, Rein, Sites de fixation, Souris, Séquence d'acides aminés, Virulence.

English descriptors

KwdEn :
- Amino Acid Sequence, Animals, Binding Sites, Carcinoembryonic Antigen (physiology), Cell Line, Cell Membrane (virology), Coronavirus (classification), Coronavirus (pathogenicity), Coronavirus (physiology), Coronavirus Infections (physiopathology), Cricetinae, Heparitin Sulfate (metabolism), Kidney, Mice, Protein Binding, Receptors, Virus (physiology), Virulence.
MESH :
- chemical , metabolism : Heparitin Sulfate.
- chemical , physiology : Carcinoembryonic Antigen, Receptors, Virus.
- classification : Coronavirus.
- pathogenicity : Coronavirus.
- physiology : Coronavirus.
- physiopathology : Coronavirus Infections.
- virology : Cell Membrane.
- Amino Acid Sequence, Animals, Binding Sites, Cell Line, Cricetinae, Kidney, Mice, Protein Binding, Virulence.

Abstract

A highly neurovirulent mouse hepatitis virus (MHV) JHMV strain (wt) with receptor (MHVR)-independent infection activity and its low-virulent mutant srr7 without such activity were found to attach to MHVR-negative, non-permissive BHK cells. To identify the molecule that interacts with JHMV, we focused on heparan sulfate (HS) since it works as a receptor of a mutant MHV-rec1 that infects in an MHVR-independent fashion. The present study indicates that HS interacts with both wt JHMV and srr7 but it does not function as an entry receptor as it apparently does for MHV-rec1. Furthermore, HS failed to serve as an entry receptor in the MHVR-independent infection of wt JHMV, indicating that HS is not a host factor that wt JHMV utilizes in an MHVR-independent infection.

DOI: 10.1016/j.virol.2007.06.034
PubMed: 17692355

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 001D49
to stream PubMed, to step Curation: 001D49
to stream PubMed, to step Checkpoint: 001D98

Links to Exploration step

pubmed:17692355

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Heparan sulfate is a binding molecule but not a receptor for CEACAM1-independent infection of murine coronavirus.</title>
<author><name sortKey="Watanabe, Rie" sort="Watanabe, Rie" uniqKey="Watanabe R" first="Rie" last="Watanabe">Rie Watanabe</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Viral Respiratory Diseases and SARS, Department of Virology III, National Institute of Infectious Diseases, Murayama Branch, 4-7-1 Gakuen, Musashi-Murayama, Tokyo 208-0011, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Division of Viral Respiratory Diseases and SARS, Department of Virology III, National Institute of Infectious Diseases, Murayama Branch, 4-7-1 Gakuen, Musashi-Murayama, Tokyo 208-0011</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sawicki, Stanley G" sort="Sawicki, Stanley G" uniqKey="Sawicki S" first="Stanley G" last="Sawicki">Stanley G. Sawicki</name>
</author>
<author><name sortKey="Taguchi, Fumihiro" sort="Taguchi, Fumihiro" uniqKey="Taguchi F" first="Fumihiro" last="Taguchi">Fumihiro Taguchi</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2007">2007</date>
<idno type="RBID">pubmed:17692355</idno>
<idno type="pmid">17692355</idno>
<idno type="doi">10.1016/j.virol.2007.06.034</idno>
<idno type="wicri:Area/PubMed/Corpus">001D49</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001D49</idno>
<idno type="wicri:Area/PubMed/Curation">001D49</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001D49</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001D98</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001D98</idno>
<idno type="wicri:Area/Ncbi/Merge">001A37</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Heparan sulfate is a binding molecule but not a receptor for CEACAM1-independent infection of murine coronavirus.</title>
<author><name sortKey="Watanabe, Rie" sort="Watanabe, Rie" uniqKey="Watanabe R" first="Rie" last="Watanabe">Rie Watanabe</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Viral Respiratory Diseases and SARS, Department of Virology III, National Institute of Infectious Diseases, Murayama Branch, 4-7-1 Gakuen, Musashi-Murayama, Tokyo 208-0011, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Division of Viral Respiratory Diseases and SARS, Department of Virology III, National Institute of Infectious Diseases, Murayama Branch, 4-7-1 Gakuen, Musashi-Murayama, Tokyo 208-0011</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sawicki, Stanley G" sort="Sawicki, Stanley G" uniqKey="Sawicki S" first="Stanley G" last="Sawicki">Stanley G. Sawicki</name>
</author>
<author><name sortKey="Taguchi, Fumihiro" sort="Taguchi, Fumihiro" uniqKey="Taguchi F" first="Fumihiro" last="Taguchi">Fumihiro Taguchi</name>
</author>
</analytic>
<series><title level="j">Virology</title>
<idno type="ISSN">0042-6822</idno>
<imprint><date when="2007" type="published">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amino Acid Sequence</term>
<term>Animals</term>
<term>Binding Sites</term>
<term>Carcinoembryonic Antigen (physiology)</term>
<term>Cell Line</term>
<term>Cell Membrane (virology)</term>
<term>Coronavirus (classification)</term>
<term>Coronavirus (pathogenicity)</term>
<term>Coronavirus (physiology)</term>
<term>Coronavirus Infections (physiopathology)</term>
<term>Cricetinae</term>
<term>Heparitin Sulfate (metabolism)</term>
<term>Kidney</term>
<term>Mice</term>
<term>Protein Binding</term>
<term>Receptors, Virus (physiology)</term>
<term>Virulence</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Antigène carcinoembryonnaire (physiologie)</term>
<term>Coronavirus ()</term>
<term>Coronavirus (pathogénicité)</term>
<term>Coronavirus (physiologie)</term>
<term>Cricetinae</term>
<term>Héparitine sulfate (métabolisme)</term>
<term>Infections à coronavirus (physiopathologie)</term>
<term>Liaison aux protéines</term>
<term>Lignée cellulaire</term>
<term>Membrane cellulaire (virologie)</term>
<term>Rein</term>
<term>Récepteurs viraux (physiologie)</term>
<term>Sites de fixation</term>
<term>Souris</term>
<term>Séquence d'acides aminés</term>
<term>Virulence</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Heparitin Sulfate</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en"><term>Carcinoembryonic Antigen</term>
<term>Receptors, Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Héparitine sulfate</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Antigène carcinoembryonnaire</term>
<term>Coronavirus</term>
<term>Récepteurs viraux</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Infections à coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Membrane cellulaire</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Cell Membrane</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Amino Acid Sequence</term>
<term>Animals</term>
<term>Binding Sites</term>
<term>Cell Line</term>
<term>Cricetinae</term>
<term>Kidney</term>
<term>Mice</term>
<term>Protein Binding</term>
<term>Virulence</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Coronavirus</term>
<term>Cricetinae</term>
<term>Liaison aux protéines</term>
<term>Lignée cellulaire</term>
<term>Rein</term>
<term>Sites de fixation</term>
<term>Souris</term>
<term>Séquence d'acides aminés</term>
<term>Virulence</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">A highly neurovirulent mouse hepatitis virus (MHV) JHMV strain (wt) with receptor (MHVR)-independent infection activity and its low-virulent mutant srr7 without such activity were found to attach to MHVR-negative, non-permissive BHK cells. To identify the molecule that interacts with JHMV, we focused on heparan sulfate (HS) since it works as a receptor of a mutant MHV-rec1 that infects in an MHVR-independent fashion. The present study indicates that HS interacts with both wt JHMV and srr7 but it does not function as an entry receptor as it apparently does for MHV-rec1. Furthermore, HS failed to serve as an entry receptor in the MHVR-independent infection of wt JHMV, indicating that HS is not a host factor that wt JHMV utilizes in an MHVR-independent infection.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17692355</PMID>
<DateCompleted><Year>2007</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>01</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0042-6822</ISSN>
<JournalIssue CitedMedium="Print"><Volume>366</Volume>
<Issue>1</Issue>
<PubDate><Year>2007</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Virology</Title>
<ISOAbbreviation>Virology</ISOAbbreviation>
</Journal>
<ArticleTitle>Heparan sulfate is a binding molecule but not a receptor for CEACAM1-independent infection of murine coronavirus.</ArticleTitle>
<Pagination><MedlinePgn>16-22</MedlinePgn>
</Pagination>
<Abstract><AbstractText>A highly neurovirulent mouse hepatitis virus (MHV) JHMV strain (wt) with receptor (MHVR)-independent infection activity and its low-virulent mutant srr7 without such activity were found to attach to MHVR-negative, non-permissive BHK cells. To identify the molecule that interacts with JHMV, we focused on heparan sulfate (HS) since it works as a receptor of a mutant MHV-rec1 that infects in an MHVR-independent fashion. The present study indicates that HS interacts with both wt JHMV and srr7 but it does not function as an entry receptor as it apparently does for MHV-rec1. Furthermore, HS failed to serve as an entry receptor in the MHVR-independent infection of wt JHMV, indicating that HS is not a host factor that wt JHMV utilizes in an MHVR-independent infection.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Watanabe</LastName>
<ForeName>Rie</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Division of Viral Respiratory Diseases and SARS, Department of Virology III, National Institute of Infectious Diseases, Murayama Branch, 4-7-1 Gakuen, Musashi-Murayama, Tokyo 208-0011, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sawicki</LastName>
<ForeName>Stanley G</ForeName>
<Initials>SG</Initials>
</Author>
<Author ValidYN="Y"><LastName>Taguchi</LastName>
<ForeName>Fumihiro</ForeName>
<Initials>F</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2007</Year>
<Month>08</Month>
<Day>09</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Virology</MedlineTA>
<NlmUniqueID>0110674</NlmUniqueID>
<ISSNLinking>0042-6822</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D002272">Carcinoembryonic Antigen</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C486183">Ceacam1 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011991">Receptors, Virus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>9050-30-0</RegistryNumber>
<NameOfSubstance UI="D006497">Heparitin Sulfate</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002272" MajorTopicYN="N">Carcinoembryonic Antigen</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002462" MajorTopicYN="N">Cell Membrane</DescriptorName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017934" MajorTopicYN="N">Coronavirus</DescriptorName>
<QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
<QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006497" MajorTopicYN="N">Heparitin Sulfate</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011991" MajorTopicYN="N">Receptors, Virus</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2007</Year>
<Month>03</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2007</Year>
<Month>06</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2007</Year>
<Month>06</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2007</Year>
<Month>8</Month>
<Day>19</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2007</Year>
<Month>11</Month>
<Day>14</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2007</Year>
<Month>8</Month>
<Day>19</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">17692355</ArticleId>
<ArticleId IdType="pii">S0042-6822(07)00463-1</ArticleId>
<ArticleId IdType="doi">10.1016/j.virol.2007.06.034</ArticleId>
<ArticleId IdType="pmc">PMC7103320</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Med Res Rev. 2002 Jan;22(1):1-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11746174</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2005 May;79(10):6102-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15857995</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2001 Mar;75(6):2792-802</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11222703</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2005 Nov;79(22):14451-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16254381</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1997 Dec;71(12):9499-507</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9371612</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1997 Apr;71(4):3129-37</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9060676</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1999 Jan;73(1):638-49</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9847369</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2006 Nov;80(22):10909-18</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16956938</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2001 May;75(10):4528-39</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11312323</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 1992 Nov;191(1):517-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1413526</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1997 Dec;71(12):9024-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9371559</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2004 Sep;78(17):9073-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15308703</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1991 Dec;65(12):6881-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1719235</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1997 Mar;71(3):1946-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9032326</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2004 Jul;78(14):7828-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15220458</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2006 May;80(10):4901-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16641281</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1998 Sep;72(9):7357-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9696832</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2002 Dec;76(23):11819-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12414924</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1985 May;54(2):429-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2985806</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2002 Feb;76(3):950-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11773370</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2004 Jan;78(1):216-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14671103</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2000 Jul 20;273(1):80-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10891410</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1995 Sep;69(9):5535-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7636998</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Japon</li>
</country>
<region><li>Région de Kantō</li>
</region>
<settlement><li>Tokyo</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Sawicki, Stanley G" sort="Sawicki, Stanley G" uniqKey="Sawicki S" first="Stanley G" last="Sawicki">Stanley G. Sawicki</name>
<name sortKey="Taguchi, Fumihiro" sort="Taguchi, Fumihiro" uniqKey="Taguchi F" first="Fumihiro" last="Taguchi">Fumihiro Taguchi</name>
</noCountry>
<country name="Japon"><region name="Région de Kantō"><name sortKey="Watanabe, Rie" sort="Watanabe, Rie" uniqKey="Watanabe R" first="Rie" last="Watanabe">Rie Watanabe</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A37 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 001A37 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:17692355
   |texte=   Heparan sulfate is a binding molecule but not a receptor for CEACAM1-independent infection of murine coronavirus.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:17692355" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SRAS

Heparan sulfate is a binding molecule but not a receptor for CEACAM1-independent infection of murine coronavirus.

Heparan sulfate is a binding molecule but not a receptor for CEACAM1-independent infection of murine coronavirus.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki